Understanding brain issues in congenital Myotonic Dystrophy type 1 and exploring new treatments
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities
This study is looking at how congenital Myotonic Dystrophy type 1 affects the brain and is testing a new drug that might help improve brain function and reduce anxiety for people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10773028 on NIH RePORTER |
What this research studies
This research investigates how congenital Myotonic Dystrophy type 1 (DM1) affects the brain and seeks to identify potential therapeutic options. The study focuses on the molecular mechanisms behind CNS dysfunction in DM1, particularly how certain proteins are misregulated due to genetic mutations. By using a mouse model, researchers are testing a drug that inhibits a specific enzyme to see if it can improve brain function and reduce anxiety. The findings from this research could lead to new treatment strategies for patients with DM1.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with congenital Myotonic Dystrophy type 1, particularly those experiencing cognitive and neurological challenges.
Not a fit: Patients with other forms of Myotonic Dystrophy or those without CNS involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cognitive function and quality of life for patients with congenital Myotonic Dystrophy type 1.
How similar studies have performed: Previous clinical trials have shown promising results with similar approaches, indicating potential for success in this area.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Timchenko, Lubov T — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Timchenko, Lubov T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.